/ /

Ophthalmology

New therapies for uveal melanoma target radiation toxicity, metastatic riskOngoing research for the treatment of uveal melanoma is providing hope that the future may bring new approaches for improving the safety of local therapy–along with modalities that will increase survival by reducing metastatic risk.
How to attract millennials to your practice
How to attract millennials to your practiceFaced with an increasingly competitive environment, eye surgeons need to appeal to younger patients. The way to accomplish this is relatively straightforward: Be where they are. Of course, the more challenging part of this equation is “How?”
Reduced risk of CNV after SDM laser retinal protective therapyThe dry form of age-related macular degeneration (AMD) is the most common type of the disease, but successful treatments have been elusive in patients, resulting in disease progress and visual loss.
Topical cetirizine latest therapy to treat allergic conjunctivitisOral cetirizine is one of the most used oral medications for treatment of allergic rhinitis. In May 2017, the FDA approved the first ophthalmic formulation of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis.
Do you use irrigation dynamic pressure-assisted hydrodissection?Findings in the journal Clinical Ophthalmology report that using the technique phacoemulsification was performed without complications in 607 of 609 cataract eyes.
Diagnosing and treating MacTel degenerative retinal diseaseIdiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and atrophy of the neurosensory retina. Familiarity with the distinctive intraretinal cavitation on SD-OCT in type 2, the most common type, is key for correct diagnosis.
Something we may be missing
Something we may be missingMy friend, Dave, an oculoplastic surgeon, trained the same time I did. He was extremely intelligent and possessed a great sense of humor. A real jokester, he provided free cosmetic services to his office staff, and claimed in their presence that his treatments prevented them from frowning at him.
Scleral implant for presbyopia making accommodative gains
Scleral implant for presbyopia making accommodative gainsImplantation of an investigational device for presbyopia resulted in a minimal 2-line increase in distance-corrected near visual acuity and an actual reduction in the amount of near add needed over time, show findings from a single-center, subgroup analysis.
Deeper implantation depth for inlay may enhance visual performanceA comparative analysis suggests placement of a cornea inlay (Kamra, AcuFocus) has improved patient satisfaction, refractive stability, and visual results when placed at 250 μm or deeper in the cornea. Shallower implantation depths may be more prone to refractive instability and lower patient satisfaction.
PiXL appears promising for low myopiaThe use of epi-on photorefractive intrastromal cross linking reduced myopia by about 0.25 D in a small study; In a high-oxygen group, the effect averaged 1.25 D.